# P19.040.A Author List and Affiliations

**Assessing Idiopathic Pulmonary Fibrosis Genetic Risk Variants Beyond European Populations**

**Authors:**  
Ritah Nabunje<sup>1,2</sup>, Tamara Hernandez-Beeftink<sup>1,2</sup>, Beatriz Guillen-Guio<sup>1,2,3</sup>, Ayodeji Adegunsoye<sup>4</sup>, Helen Booth<sup>5</sup>, Paul Cullinan<sup>6</sup>, 
William A Fahy<sup>7</sup>, Ian P Hall<sup>8</sup>, Simon P Hart<sup>9</sup>, Mike R Hill<sup>10</sup>, Nik Hirani<sup>11</sup>, Richard B Hubbard<sup>8</sup>, 
Simon Johnson<sup>12</sup>, Naftali Kaminski<sup>13</sup>, Jose Miguel Lorenzo-Salazar<sup>14</sup>, Shwu-Fan Ma<sup>15</sup>, Fernando Martinez<sup>16</sup>, 
Robin J McAnulty<sup>17</sup>, Toby M Maher<sup>18</sup>, Ann B Millar<sup>19</sup>, Philip L Molyneaux<sup>20</sup>, Maria Molina-Molina<sup>3,21,22</sup>, 
Vidya Navaratnam<sup>23,24</sup>, Justin M Oldham<sup>25</sup>, Helen Parfrey<sup>26</sup>, Gauri Sain<sup>i8</sup>, Ian Sayers<sup>27</sup>, Iain D Stewart<sup>28</sup>, 
Mary E Strek<sup>4</sup>, Martin D Tobin<sup>1,2</sup>, Moira KB Whyte<sup>11</sup>, Yingze Zhang<sup>29</sup>, Carlos Flores<sup>3,14,30,31</sup>, Imre Noth<sup>15</sup>,
R Gisli Jenkins<sup>18</sup>, Louise V Wain<sup>1,2</sup>, Richard J Allen<sup>1,2</sup>

**Affiliations:**  
<sup>1</sup> Department of Population Health Sciences, University of Leicester, Leicester, UK   
<sup>2</sup> NIHR Leicester Biomedical Research Centre, Leicester, UK  
<sup>3</sup> Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain  
<sup>4</sup> University of Chicago, Chicago, USA 
<sup>5</sup> University College London Hospitals, London, UK  
<sup>6</sup> Imperial College, London, UK  
<sup>7</sup> GlaxoSmithKline, London, UK
<sup>8</sup> University of Nottingham, Nottingham, UK
<sup>9</sup> University of Hull, Hull, UK  
<sup>10</sup> University of Oxford, Oxford, UK  
<sup>11/sup> University of Edinburgh, Edinburgh, UK  
<sup>12</sup> Division of Respiratory Medicine and Respiratory Research Unit, University of Nottingham, Nottingham, UK
<sup>13</sup> Yale School of Medicine, Connecticut, USA
<sup>14</sup> Genomics Division, Instituto Tecnologico y de Energias Renovables, Santa Cruz de Tenerife, Spain  
<sup>15</sup> University of Virginia, Virginia, USA
<sup>16</sup> Weill Cornell Medicine, New York, USA
<sup>17</sup> University College London, London, UK  
<sup>18</sup> NIHR Imperial Biomedical Research Unit, National Heart and Lung Institute, Imperial College London, London, UK  
<sup>19</sup> University of Bristol, Bristol, UK  
<sup>20</sup> National Institute for Health Research Respiratory Clinical Research Facility, Royal Brompton Hospital, London, UK
<sup>21</sup> Servei de Pneumologia, Laboratori de Pneumologia Experimental, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain  
<sup>22</sup> Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain  
<sup>23</sup> Department of Respiratory Medicine, Sir Charles Gardiner Hospital, Perth, Australia  
<sup>24</sup> Centre for Respiratory Research, University of Western Australia, Perth, Australia
<sup>25</sup> University of Michigan, Michigan, USA  
<sup>26</sup> Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK  
<sup>27</sup> Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK  
<sup>28</sup> Imperial College London, London, UK
<sup>29</sup> University of Pittsburgh, Pittsburgh, USA  
<sup>30</sup> Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Instituto de Investigación Sanitaria de Canarias, Santa Cruz de Tenerife, Spain  
<sup>31</sup> Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain


---

For questions or collaboration, please contact the presenting author: **[rn180@leicester.ac.uk]**
